Gepotidacin was approved by the FDA earlier this year, under the Blujepa brand, as the first oral antibiotic to offer a new ...

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who ...

One near-term rival is Johnson & Johnson's FcRn inhibitor nipocalimab, which started a phase 3 programme last December.

One major and often overlooked factor contributing to this imbalance is the way health outcomes are measured in clinical ...

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on the gene therapy's approved labelling. The new label restricts use of the ...

It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to ...

Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

A jury in the US has found that tech giant Meta illegally compromised the privacy of a US woman who shared her data with a ...

In Part Two, putting theory into practice is addressed.

The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...